Soleno Therapeutics(SLNO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SLNO Soleno Therapeutics

Market Closed 05-24 16:00:00 EDT

41.16

-0.01

-0.02%

盘后41.16

+0.000.00%

19:29 EDT

High42.43	Low40.68	Vol302.60K
Open41.36	D1 Closing41.17	Amplitude4.25%
Mkt Cap1.50B	Tradable Cap699.85M	Total Shares36.41M
T/O12.52M	T/O Rate1.78%	Tradable Shares17.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"SLNO","market":"US","secType":"STK","nameCN":"Soleno Therapeutics","latestPrice":41.16,"timestamp":1716580800000,"preClose":41.17,"halted":0,"volume":302602,"hourTrading":{"tag":"盘后","latestPrice":41.16,"preClose":41.16,"latestTime":"19:29 EDT","volume":71794,"amount":2955040.2147,"timestamp":1716593387957},"delay":0,"floatShares":17003200,"shares":36411300,"eps":-2.244376,"marketStatus":"Market Closed","change":-0.01,"latestTime":"05-24 16:00:00 EDT","open":41.36,"high":42.43,"low":40.68,"amount":12519640.30058,"amplitude":0.042507,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.244376,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1716883200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":41.17,"postHourTrading":{"tag":"盘后","latestPrice":41.16,"preClose":41.16,"latestTime":"19:29 EDT","volume":71794,"amount":2955040.2147,"timestamp":1716593387957},"volumeRatio":0.8208168589132914,"impliedVol":0.7188,"impliedVolPercentile":0.0584},"requestUrl":"/m/hq/s/SLNO/wiki","defaultTab":"wiki","newsList":[{"id":"2437387732","title":"Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Soleno Therapeutics (SLNO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2437387732","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2437387732?lang=en_us&edition=fundamental","pubTime":"2024-05-23 19:00","pubTimestamp":1716462043,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cytokinetics (CYTK – Research Report), Soleno Therap...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-cytokinetics-cytk-soleno-therapeutics-slno?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-cytokinetics-cytk-soleno-therapeutics-slno?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2437243904","title":"Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2437243904","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2437243904?lang=en_us&edition=fundamental","pubTime":"2024-05-22 20:05","pubTimestamp":1716379500,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., May  22, 2024  (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/22/2886835/0/en/Soleno-Therapeutics-Announces-Oral-Presentation-featuring-DCCR-Diazoxide-Choline-Extended-Release-Tablets-in-Prader-Willi-Syndrome-at-ENDO-2024.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435631757","title":"Soleno Therapeutics Stands with the Prader-Willi Syndrome Community","url":"https://stock-news.laohu8.com/highlight/detail?id=2435631757","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2435631757?lang=en_us&edition=fundamental","pubTime":"2024-05-15 12:00","pubTimestamp":1715745600,"startTime":"0","endTime":"0","summary":"This Prader-Willi Syndrome Awareness Day, May 15, join Soleno Therapeutics in sharing messages of hope and kindness for the Prader-Willi syndrome communityREDWOOD CITY, Calif., May  15, 2024  (GLOBE N","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/15/2882351/0/en/Soleno-Therapeutics-Stands-with-the-Prader-Willi-Syndrome-Community.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435327975","title":"Soleno Therapeutics Is Maintained at Outperform by Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2435327975","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2435327975?lang=en_us&edition=fundamental","pubTime":"2024-05-13 20:46","pubTimestamp":1715604360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SLNO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 13, 2024 08:46 ET (12:46 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2434633008","title":"Solerno a new outperform at Baird on lead candidate for Prader-Willi syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2434633008","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2434633008?lang=en_us&edition=fundamental","pubTime":"2024-05-10 23:19","pubTimestamp":1715354355,"startTime":"0","endTime":"0","summary":"Baird has initiated Solerno Therapeutics (NASDAQ:SLNO) with a buy rating saying that they view U.S. approval of the company's lead asset, an extended-release formulation of diazoxide choline (DCCR) fo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4104692-solerno-new-outperform-baird-lead-candidate-prader-willi-syndrome","is_publish_highlight":false,"gpt_icon":0},{"id":"2434833677","title":"Soleno Therapeutics Initiated at Outperform by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2434833677","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2434833677?lang=en_us&edition=fundamental","pubTime":"2024-05-10 17:29","pubTimestamp":1715333340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SLNO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 10, 2024 05:29 ET (09:29 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2434035026","title":"Soleno Therapeutics GAAP EPS of -$0.59 misses by $0.22","url":"https://stock-news.laohu8.com/highlight/detail?id=2434035026","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2434035026?lang=en_us&edition=fundamental","pubTime":"2024-05-10 05:51","pubTimestamp":1715291475,"startTime":"0","endTime":"0","summary":"Soleno Therapeutics press release  (NASDAQ:SLNO): Q1  GAAP EPS of -$0.59  misses by $0.22.\nAs of March 31, 2024, Soleno had $42.8 million of cash and cash equivalents, $106.8 million of short-term investments, and $8.8 million of long-term investments.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4104315-soleno-therapeutics-gaap-eps-of-0_59-misses-0_22","is_publish_highlight":false,"gpt_icon":0},{"id":"2434025575","title":"Soleno Therapeutics Q1 2024 Adj EPS $(0.59) Misses $(0.37) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2434025575","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2434025575?lang=en_us&edition=fundamental","pubTime":"2024-05-10 05:19","pubTimestamp":1715289582,"startTime":"0","endTime":"0","summary":"Soleno Therapeutics (NASDAQ:SLNO) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.37) by 59.46 percent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/38747518/soleno-therapeutics-q1-2024-adj-eps-0-59-misses-0-37-estimate","is_publish_highlight":false,"gpt_icon":0},{"id":"2432134927","title":"Soleno Therapeutics Inc    expected to post a loss of 37 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2432134927","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2432134927?lang=en_us&edition=fundamental","pubTime":"2024-05-03 19:02","pubTimestamp":1714734138,"startTime":"0","endTime":"0","summary":"* Soleno Therapeutics Inc     is expected to show no change in quarterly revenue when it reports  results on May 7 (estimated) for the period ending March 31 2024   *    * LSEG's mean analyst estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432470994","title":"BRIEF-Soleno Therapeutics Announces Pricing Of Approximately $138 Million Public Offering Of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2432470994","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2432470994?lang=en_us&edition=fundamental","pubTime":"2024-05-03 10:34","pubTimestamp":1714703648,"startTime":"0","endTime":"0","summary":"May 2  - Soleno Therapeutics Inc   :   * SOLENO THERAPEUTICS ANNOUNCES PRICING OF APPROXIMATELY $138 MILLION PUBLIC OFFERING OF COMMON STOCK   * SOLENO THERAPEUTICS INC - PRICING OF UNDERWRITTEN PUBLIC OFFERING OF 3 MILLION SHARES OF ITS COMMON STOCK AT A PUBLIC OFFERING PRICE OF $46.00 PER SHARESource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432587379","title":"BRIEF-Soleno Therapeutics Announces Proposed Public Offering Of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2432587379","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2432587379?lang=en_us&edition=fundamental","pubTime":"2024-05-03 04:03","pubTimestamp":1714680235,"startTime":"0","endTime":"0","summary":"May 2 (Reuters) - Soleno Therapeutics Inc   :   * SOLENO THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCKSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432953197","title":"Soleno Therapeutics Announces Proposed Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2432953197","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2432953197?lang=en_us&edition=fundamental","pubTime":"2024-05-02 20:01","pubTimestamp":1714651260,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., May  02, 2024  (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc.(Nasdaq:SLNO), (\"Soleno\" or the \"Company\"), a clinical-stage biopharmaceutical company developing novel therapeutics f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/02/2874655/0/en/Soleno-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431346334","title":"Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2431346334","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2431346334?lang=en_us&edition=fundamental","pubTime":"2024-04-30 12:00","pubTimestamp":1714449600,"startTime":"0","endTime":"0","summary":"Statistically Significant Improvements with DCCR Compared to Natural History of PWSfrom the PATH for PWS Study in Hyperphagia and PWS-related BehaviorsREDWOOD CITY, Calif., April  30, 2024  (GLOBE NEW","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/04/30/2872164/0/en/Soleno-Therapeutics-Announces-Peer-Reviewed-Publication-of-Data-Comparing-DCCR-Treatment-to-the-Natural-History-of-Prader-Willi-Syndrome.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431484296","title":"Soleno: Mid-2024 NDA Filing For PWS Treatment Is A Major Catalyst To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2431484296","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2431484296?lang=en_us&edition=fundamental","pubTime":"2024-04-30 04:02","pubTimestamp":1714420936,"startTime":"0","endTime":"0","summary":"That's because it spoke with the FDA and the agency stated that if it was able to have a successful randomized withdrawal study,","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4687282-soleno-mid-2024-nda-filing-for-pws-treatment-is-a-major-catalyst-to-watch","is_publish_highlight":false,"gpt_icon":0},{"id":"2431189061","title":"FLGC, BTOG and CAUD among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2431189061","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2431189061?lang=en_us&edition=fundamental","pubTime":"2024-04-30 00:31","pubTimestamp":1714408290,"startTime":"0","endTime":"0","summary":"Gainers: Collective Audience  +93%. Deciphera Pharmaceuticals  +72%. HWH International  +40%. Mullen Automotive  +32%. SEP Acquisition Corp  +30%. Bit Origin Ltd  +30%. SINTX Technologies  +32%. Koninklijke Philips N.V.  +28%. Phibro Animal Health Corp.  +27%.  Soleno Therapeutics  +25%.  Losers: Clever Leaves Holdings  -61%. Annovis Bio  -56%. Addex Therapeutics Ltd  -48%. mF International Ltd  -32%. Avenue Therapeutics  -23%. Intelligent Group Ltd  -19%. Nature Wood Group Ltd  -19%. Flora Growth Corp  -18%. China Jo-Jo Drugstores  -17%. Fitell Corp  -17%.","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4095678-flgc-btog-and-caud-among-mid-day-movers","is_publish_highlight":false,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.soleno.life","stockEarnings":[{"period":"1week","weight":-0.1083},{"period":"1month","weight":0.0463},{"period":"3month","weight":-0.16},{"period":"6month","weight":0.4257},{"period":"1year","weight":7.1829},{"period":"ytd","weight":0.0226}],"compareEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0475},{"period":"3month","weight":0.0425},{"period":"6month","weight":0.1628},{"period":"1year","weight":0.2768},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.036312},{"month":2,"riseRate":0.3,"avgChangeRate":0.282888},{"month":3,"riseRate":0.6,"avgChangeRate":-0.03782},{"month":4,"riseRate":0.4,"avgChangeRate":0.050488},{"month":5,"riseRate":0.6,"avgChangeRate":0.081494},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.099954},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.087265},{"month":8,"riseRate":0.555556,"avgChangeRate":0.004333},{"month":9,"riseRate":0.444444,"avgChangeRate":0.497463},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.150541},{"month":11,"riseRate":0.555556,"avgChangeRate":0.016977},{"month":12,"riseRate":0.4,"avgChangeRate":0.085183}],"exchange":"NASDAQ","name":"Soleno Therapeutics","nameEN":"Soleno Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Soleno Therapeutics(SLNO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Soleno Therapeutics(SLNO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Soleno Therapeutics,SLNO,Soleno Therapeutics股票,Soleno Therapeutics股票老虎,Soleno Therapeutics股票老虎国际,Soleno Therapeutics行情,Soleno Therapeutics股票行情,Soleno Therapeutics股价,Soleno Therapeutics股市,Soleno Therapeutics股票价格,Soleno Therapeutics股票交易,Soleno Therapeutics股票购买,Soleno Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Soleno Therapeutics(SLNO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Soleno Therapeutics(SLNO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction